<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: intravenous drug</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>New anti-clotting drug more effective than current treatment</title>
   	 <description>A new and experimental anti-clotting drug, cangrelor, proved better than the commonly used clopidogrel and was significantly more effective at preventing blood clots in a large trial of patients who underwent coronary stent procedures. These data, from the phase III CHAMPION PHOENIX study, were presented at the American College of Cardiology's 62nd Annual Scientific Session and published simultaneously in the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-anti-clotting-drug-effective-current-treatment.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 11 Mar 2013 10:21:55 EST</pubDate>
	 <guid isPermaLink="false">news282216106</guid>
	 
</item>
<item>
     <title>FDA panel recommends against 1st drug for chronic fatigue syndrome</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.</description>
     <link>http://medicalxpress.com/news/2012-12-fda-panel-1st-drug-chronic_1.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 21 Dec 2012 10:40:42 EST</pubDate>
	 <guid isPermaLink="false">news275308835</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelreco.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel considers 1st drug for chronic fatigue syndrome</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory committee will meet Thursday to consider approval of the first drug to treat chronic fatigue syndrome.</description>
     <link>http://medicalxpress.com/news/2012-12-fda-panel-1st-drug-chronic.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 20 Dec 2012 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news275229003</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelcons.jpg" width="90" height="90" />
</item>
<item>
     <title>Hepatitis risk a concern for baby boomers</title>
   	 <description>(Medical Xpress)—Older adults are asking more questions about liver health now that the Centers for Disease Control and Prevention has formally called for baby boomers to get tested for Hepatitis C, says Dr. Luis Balart, chief of gastroenterology and hepatology at Tulane Medical Center.</description>
     <link>http://medicalxpress.com/news/2012-09-hepatitis-baby-boomers.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 24 Sep 2012 08:06:04 EST</pubDate>
	 <guid isPermaLink="false">news267692753</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/hepatitisris.jpg" width="90" height="90" />
</item>
<item>
     <title>Recovery from propofol anesthesia may be sped by use of common stimulant</title>
   	 <description>The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.</description>
     <link>http://medicalxpress.com/news/2012-04-recovery-propofol-anesthesia-sped-common.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 05 Apr 2012 14:55:57 EST</pubDate>
	 <guid isPermaLink="false">news252856538</guid>
	 
</item>
<item>
     <title>Research demonstrates bacterial contamination in pharmacy robots</title>
   	 <description>Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.</description>
     <link>http://medicalxpress.com/news/2012-04-bacterial-contamination-pharmacy-robots.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 04 Apr 2012 11:20:23 EST</pubDate>
	 <guid isPermaLink="false">news252757209</guid>
	 
</item>
<item>
     <title>Russia HIV infections rise 5% in 2011: official</title>
   	 <description> Russia in 2011 saw a rise of five percent in the number of new HIV infections to 62,000 cases amid worrying signs that heterosexuals and women are increasingly at risk, its chief doctor said Monday.</description>
     <link>http://medicalxpress.com/news/2012-03-russia-hiv-infections.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 12 Mar 2012 13:46:20 EST</pubDate>
	 <guid isPermaLink="false">news250778774</guid>
	 
</item>


</channel>
</rss>
